A novel drug almost entirely cleared moderate to severe psoriasis in over 60% of the patients who took part in two phase three clinical trials of a new drug. The University of Manchester and Salford ...

Dermavant has high hopes for the cream because it provides an alternative to topical corticosteroid drugs ... start for the new product. The main problem is that the market for psoriasis therapies ...

and BMS says it now plans to launch the new drug later this month, aiming to mount a challenge to Amgen's $2.3 billion oral psoriasis therapy Otezla (apremilast). BMS has previously said it ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased ...

psoriasis drugs market is expected to expand significantly, growing from an estimated USD 19.65 billion in 2024 ...

This page is a valuable resource, featuring a complete guide to the latest medications-both generic and branded-ideal for relieving Psoriasis symptom. Learn about various drugs, from their dosages ...